Implications of benzodiazepines in drug related deaths
|
|
- Rodney Powell
- 6 years ago
- Views:
Transcription
1 Implications of benzodiazepines in drug related deaths Analyses of the french special mortality register data (DRAMES) Dr Michel Mallaret CEIP-Addictovigilance Grenoble France Lisboa, october 15th 2014
2 Gaba modulators (agonists) and deaths Ethyl alcohol binge drinking and deaths Barbiturates : restriction of access deaths in case of abuse (or suicide) Benzodiazepines : initially supposed to be safe Less respiratory depression / barbiturates Less toxicity Pharmacodynamic tolerance in dependent patients
3 French context of benzodiazepine (BZD) (The «French paradox») French alcohol dependence (12.6 Litres consumed per capita in 2011) Anxiolytics and hypnotics (BZD + Z..) easily available by M.D. prescription Abuse, misuse cases ; huge population with long term dependence Alternatives of BZD (more expensive) are not enough favoured Restriction of BZD access? Increase of alcohol consumption? Even the association BZD accidents, hypomnesia or potential risk of Alzheimer s disease (Billioti de Gage et al.,2014) does not change prescription habits
4 BZD users prevalence in France
5 Anxiolytics (fig.1)and hypnotics (fig.2)use (DDD/1.000 hab)in Europe
6 EU and US warnings: benzodiazepines should be avoided in Opioid Maintenance Treatment (OMT) Risk of respiratory depression, especially in case of misuse Risk of misuse Contribute to relapse? (Brands et al., 2008) Development of psychological coping stategies is hindered (Soyka et al., 2010) Unsufficient dose of methadone or BHD? Retention in generalised anxiety disorder is low : interest of BDZ? (Liebrenz et al., 2010) Patients are often yet BZD dependent : reduction trial
7 Benzodiazepines and ED visits, fatalities in the world BZD and ED visits (USA;DAWN (Gudin et al., 2014) ) Benzodiazepine Deaths and alprazolam (Florida, Johnson, 2014) Alprazolam Deaths and BZD and methadone Norway (Bernard et al.,2013) Benzodiazepine
8 Experimental studies of benzodiazepines and interactions of benzodiazepine and buprenorphine Cross-tolerance in Rats may not occur between 2 agonists : risks of sedation (Vinkers et al, 2012)and respiratory depressionin case of BDZ change : BZD+buprenorphine in Rats : protective bell-shaped dose response effect on respiration is eliminated (Nielsen and Taylor, 2005)
9 In Rats, only Diazepam, when associated with BHD, induces respiratory depression in BHD (acute or chronically) treated (Cohier et al., 2014) Acute IV Bup (30 mg/kg) + diazepam (30 mg/kg) Chronic Bup (14d.1mg/kg/day) ; then acute Bup (10 mg/kg) + Diazepam (20 mg/kg)
10 Clinical evaluation of BZD and of interaction of benzodiazepine and OMT Exemple of Alprazolam overdose : more complications than other BZD? (Isbister et al., 2004) BDZ and OMT : In an US study (Schuman-Olivier et al., 2013), «few» BHD patients are BZD treated 17% of 328 BHD treated patients have BZD prescription 2,7% (n=9) : overdose related ED during first year of ttt No fatalities during ttt Risk of fatalities if : Intravenous injection or snorting of opioid agonist (buprenorphine) Ongoing illicit use of full agonist opioids (Bell et al., 2009 ; Samhsha, 2011) Dropout from treatment (Clausen et al., 2008 ; Rosca et al., 2012)
11 Fatalities in OMT and benzodiazepine treated patients in France Overdose deaths in buprenorphine + BZD treated patients (Reynaud et al., 1998) BZD misuse is common in French patients (OMT) : 31% of problematic use in past month in BHDtreated (Lavie et al., 2009)
12 Association of benzodiazepine and buprenorphine or methadone in France In addiction Centers (CSAPA; OPPIDUM) : 24% Patients consulting G.P. s (OPEMA) : 30% Systematic analysis in syringes : variable % of BDZ (1 à 45%)
13 % illicit purchase ; forgeries of prescription of BDZ by users Illicit purchase (OPPIDUM) Clonazepam : 36.6% Oxazepam : 22.1% Lorazepam : 21.9% Buprenorphine HD:13.5% Methadone : 5.9% 40 Prescription sheet forgeries in Europe : BDZ : differences between countries Belgique Espagne France 20 0 % de citations sur le nombre d'osiap Alprazolam Bromazepam Buprenorphine Clorazepate Diazepam Flunitrazepam Hydrocodone Lorazepam Methylphenidate Morphine Pentazocine Thebacon Zolpidem Zopiclone
14 French drug users and deaths French drug problematic users : (Costes, 2009); more than 50% are buprenorphine or methadone users persons use buprenorphine and methadone ( ) (47 000) in 2012 Drug induced deaths in France in 2007 (capturerecapture) : persons (Janssen, 2011)
15 DRD France Methodology of D.R.A.M.E.S. data register (Décès en Relation avec Abus de Médicaments Et Substances) Systematic complete toxicological analysis and forensic study with autopsy Exclusion of suicide cases and car crash accidents Expertise of each case and imputability of each substance Cases of responsible drugs with no other cause of death Cases of partial participation of drug in death (ex. : LSD and drowning)
16 Drug related deaths (DRAMES) in France 446 received cases 346 included cases Deaths with no other causes Nb of experts (toxicologists) 310 directly drug related deaths 36 drug related deaths with other causes
17 DRD France Interests of DRAMES data register Systematic complete toxicological analysis Frequent forensic study with autopsy (ex : myocardial infarction and high blood [THC]) Analysis of drugs in tablets, syringes near the corpse Some informations about circumstances of death Imputability of each identified substance Other french registers : no toxicological analysis - G.P. certificate (CépiDC) - Police inquiry (OCRTIS : few cases)
18 DRD France DRAMES Biases and insufficiencies (1) Non exhaustive study (a priori, no bias in inclusion) No systematic inquiry by public prosecutor Not all analytical toxicologists are voluntary (bias of increasing number) Do not participate : a few «départements» among the french 99 in which there is an important OMT or a low OMT Number of deaths/ treated patients is underestimated
19 DRD France DRAMES Biases and insufficiencies (2) Disadvantages of anonymity Very few information about medical history Frequent unkown stage of addiction : - few known cases of naive patients (hair analysis) -Relapse(exit from jail)? - drop out patients from maintenance programs (OMT)? Unknown origin of licit drugs : -black market? - prescription sheets forgeries?
20 Other causes of deaths (drowning, ) AND Substances Identified (n) Imputability (n) Cannabis Cocaine 7 7 Buprenorphine 5 5 Methadone 3 3 Morphine 3 3 Hydroxyzine 3 3 Ethanol 3 3 Amphetamines 2 2 Atropine scopolamine drugs. n = Oxazepam 2 2 Cathinones 1 1 Ketamine 1 1
21 Drug Related deaths in France (D.R.A.M.E.S.) No other found causes: 310 in 2012 Substances 2010 (254) 2011 (277) 2012 (310) Heroin Cocaine Heroin+cocaine Methadone Buprenorphine Methadone+Bup. 7 1
22 Methadone and DRD in France 88 deaths / patients 2,0 deaths / 1000 patients [Met] median : 340 µg/l [ ] deaths / patients 2,7 deaths / 1000 patients[met] median : 382 µg/l [ ] 140 deaths / patients 3,0 deaths / 1000 patients [Met] médiane : 377 µg/l [ ] cocktail majoritaire méthadone 2010 méthadone 2011 méthadone 2012 buprénorphine 2010 buprénorphine 2011 buprénorphine 2012
23 Buprenorphine and deaths in France 44 deaths / patients 0.43 deaths / 1000 patients [Bup] médiane : 5,95 µg/l [0,3 154] 40 deaths / décès / 1000 patients [Bup] médiane : 3,2 µg/l [0,34 709,8] 47 deaths / décès / 1000 patients [Bup] médiane : 4,0 µg/l [0,2 112]
24 No great differences between BZD associated deaths and patients following OMT BDZ in DRAMES 2011 and (n=280) 2012 (n=310) Diazepam 35 (12,5%) 48 (15,5%) Nordiazepam 44 (15,7%) 61 (19,7%) Oxazepam 37 (13,2%) 57 (18,4%) Bromazepam 26 (9,3%) 29 (9,4%) Clonazepam 20 (7,1%) 9 (2,9%) Zopiclone 19 (6,8%) 12 (3,9%) Alprazolam 13 (4,6%) 12 (3,9%) Zolpidem 6 (2,1%) 4 (1,3%) Clobazam 4 3 BDZ and addict outpatients in addiction center OPPIDUM 2011 BDZ, addicts and M.D. OPEMA 2012
25 DRD France DRAMES ( ) Participation of responsible benzodiazepines Participation of benzodiazepines in 50% of total cases In very few cases (2 in 2011 ; 2 in 2013), BDZ are the only responsible substances Number of deaths : total fatalities nbre cas Cas BZD % BZD/total Nb of cases with BZD % : % of BZD / total cases
26 DRD France DRAMES ( ) Methadone and benzodiazepines Increase of methadone prescription ( 1/1.000 inhabitants in next future) Participation of BZD in 50% of methadone cases Number of deaths : Total methadone fatalities Cas Méthadone Cas Méthadone + BZD % BZD+met/met Methadone + BZD % : % of BZD in methadone cases
27 DRD France DRAMES ( ) Buprenorphine and benzodiazepines Importance of buprenorphine prescription ( 2/1.000 inhabitants) Participation of BZD in 70% of buprenorphine cases Number of deaths 80 70% : % of BZD in buprenorphine cases : total buprenorphine fatalities Cas Buprénorphine Cas Buprénorphine + BZD % BZD+bup/bup Buprenorphine + BZD
28 Conclusion Benzodiazepine implication in drug related deaths Analyses of the french special mortality register data (DRAMES) Literature shows the participation of BDZ in DRD BZD use, misuse, abuse and dependence is frequent in drug addicts Alternatives of BDZ are needed French mortality register DRAMES, despite its insufficiencies, shows : - high frequency (50%) of association of BDZ with drugs -similar (50%) methadone -higher frequency (70%) buprenorphine Prevention of BDZ use in this population is needed
VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER
VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER To promote and protect the health of all Virginians Fatal Drug Overdose Quarterly Report Edition 216.3 Publication Date: January 217 METHODS,
More informationDrug Profiles of Apprehended Drivers in Victoria
Drug Profiles of Apprehended Drivers in Victoria J Gerostamoulos, P McCaffrey, O H. Drummer and M Odell*. Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, 57-83
More information1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)
Dr. Paul A. Farnan farnan@mail.ubc.ca HealthQuest Occupational Health Corporation Alliance Medical Monitoring I have no financial interests or affiliation with any pharmaceutical industry or manufacturer
More information1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia
NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date
More informationFATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND
FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND ERKKI VUORI 12.-13.11.2012 HJELT INSTITUUTTI OIKEUSLÄÄKETIETEEN OSASTO FINLAND IS AN IDEAL COUNTRY FOR POST- MORTEM TOXICOLOGICAL INVESTIGATIONS High autopsy
More informationAlcohol and drugs among motorcycle riders compared with car and van drivers killed in road crashes in Norway during
Alcohol and drugs among motorcycle riders compared with car and van drivers killed in road crashes in Norway during 2001-2010 Asbjørg S. Christophersen and Hallvard Gjerde Norwegian Institute of Public
More informationLinking Opioid Treatment in Primary Care. Roxanne Lewin M.D.
Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals
More informationEmerging phenomena linked to drug use
Emerging phenomena linked to drug use Trends 15 This summary sets out the observations from the second year of operation of the TREND project (Tendances récentes et nouvelles drogues) (Recent trends and
More informationINTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008
INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 28 A report from the Office of Epidemiology and Planning Baltimore City Health Department
More informationWhat is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration
What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,
More informationAnnual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use
Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Report of the Government of: Reporting Year: Completed on (date): Please return completed questionnaire to: arq@unodc.org
More informationBenzodiazepines. Benzodiazepines
: History 1950s - Invented by Swiss chemists who identified its sedative effects 1950s 60s - Chlordiazepoxide (Librium) marketed as a safer alternative to barbiturates; along with newer benzodiazepines
More informationScottish Blues- Benzodiazepines and Drug Related Deaths in Scotland
Scottish Blues- Benzodiazepines and Drug Related Deaths in Scotland EMCDDA Sep. 25 th 2014 Dr Saket Priyadarshi Associate Medical Director NHS Greater Glasgow and Clyde Vice-Chair, National Forum on Drug
More informationEuropean Guidelines for Workplace Drug Testing in Blood and Blood Spots
EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in Blood and Blood Spots 9th EWDTS Symposium in Lisbon Wim Schielen 29-5-2015, Lisbon Updating project # 2 Current
More information1. Carrying Personal Medications into Thailand A. Medications containing narcotic drugs of category 2
Guidance for Travellers to Thailand under Treatment Carrying Personal Medications Containing Narcotic Drugs/Psychotropic Substances into/out of Thailand This guidance issued by the Narcotics Control Division,
More informationFindings of Drug Driving Expert Technical Panel
Findings of Drug Driving Expert Technical Panel Dr Kim Wolff Chair Reader in Addiction Science King s College London 1 Background: Government in its response to the North review indicated: Driving while
More informationPain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX
Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing
More informationORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS
ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS Barry K Logan PhD, DABFT National Director of Forensic Services, NMS Labs Willow Grove PA Disclaimer
More informationDrugs of Abuse I Serum
Drugs of Abuse I Serum 2017-11 1.10 For quality monitoring of quantitative measurements by chromatographic methods These reference materials are produced on the basis of human matrices. The highly accurate
More informationManagement of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013
Management of high risk MMT patients Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013 CFPC CoI Templates: Slide 1 Faculty Disclosure Faculty: Meldon Kahan Relationships with commercial
More informationINTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY
2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,
More informationNational Drug-Related Deaths Index
HRB Bulletin Drug Deaths 2015 National Drug-Related Deaths Index 2004 to 2015 data Overview This update presents figures from the National Drug- Related Deaths Index (NDRDI) on deaths due to poisoning
More informationDrug-related deaths and deaths among drug users in Ireland figures from the National Drug-Related Deaths Index
Drug-related deaths and deaths among drug users in Ireland 21 figures from the National Drug-Related Deaths Index January 213 Summary of 21 results This update presents figures from the National Drug-Related
More information11/1/2010. Psychology 472 Pharmacology of Psychoactive Drugs. Listen to the audio lecture while viewing these slides
Treatment for Anxiety Disorders Benzodiazepines and Other Anxiolytics Psychology 472 Pharmacology of Psychoactive Drugs Listen to the audio lecture while viewing these slides Ethanol Barbiturates and related
More informationINTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY
INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY A report from the Office of Epidemiology and Planning Baltimore
More informationUsing Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population
Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,
More informationPOLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE MARK DUNCAN, MD November 8, 2018 SPEAKER
More informationIdentification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities
Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,
More informationDrugs and Alcohol Abuse Policy
Drugs and Alcohol Abuse Policy Introduction From the beginning of 2013, there are increased requirements to provide mandatory proof of inhouse drugs and alcohol testing procedures prior to employees being
More informationEuropean Guidelines for Workplace Drug Testing in UrineandOral fluid
EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in UrineandOral fluid 9th EWDTS Symposium in Lisbon Sanna Taskinen Michaela Neuhofer Updating project # 2 Current
More informationSeptember HCMC Toxicology Transition: Additional information and Frequently Asked Questions
September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch
More informationDRIVING, DVLA, AND ADVISING PATIENTS: TOP TIPS
DRIVING, DVLA, AND ADVISING PATIENTS: TOP TIPS DR IÑIGO PEREZ MEDICAL ADVISER, DVLA GENERAL PRACTICE HOT TOPICS NOTTINGHAM 22 APRIL 2017 OUTLINE Drug driving Epilepsy concessions Fit to drive DRUG DRIVING
More information2017 Alberta Triplicate Prescription Program Atlas
Prescription Program Atlas The Prescription Program (TPP) was established in 1986 to monitor the use of certain medications prone to misuse and abuse. The mandate of the TPP is: To monitor prescribing,
More informationDRUG OVERDOSE DEATHS ANALYSIS
Overview CUYAHOGA COUNTY MEDICAL EXAMINER DRUG OVERDOSE DEATHS ANALYSIS Analysis of Fentanyl-Related Overdose Deaths in Cleveland/Cuyahoga County, Ohio in 2014 April 2015 The Cuyahoga County Medical Examiner
More informationAlcohol Use in the Elderly
Substance Use/Abuse in the Geriatric Population Alan L. Schneider, MD DFAPA DABAM Medical Director, Western Region Aetna Behavioral Health Associate Professor of Psychiatry, UCLA School of Medicine Alcohol
More informationBalancing access, quality and prevention of diversion of OST in Europe: a comparative analysis
Balancing access, quality and prevention of diversion of OST in Europe: a comparative analysis Access to OST Types of OST in France : High dose buprenorphine (HDB) (65%) Suboxone : HDB + naloxone (3%)
More informationRESPONSE TO THE DEPARTMENT FOR TRANSPORT S CONSULTATION PAPER
RESPONSE TO THE DEPARTMENT FOR TRANSPORT S CONSULTATION PAPER REGULATIONS TO SPECIFY THE DRUGS AND CORRESPONDING LIMITS FOR THE NEW OFFENCE OF DRIVING WITH A SPECIFIED CONTROLLED DRUG IN THE BODY ABOVE
More information2012 DRUG RELATED DEATH STATISTICS JANUARY 1, 2012 THROUGH DECEMBER 31, 2012
JANUARY 1, 2012 THROUGH DECEMBER 31, 2012 All deaths counted in the column labeled ACCIDENTAL OVERDOSE were the direct result of the drugs ingested by the decedent. The drugs noted as being present came
More informationDrug-related deaths and deaths among drug users in Ireland figures from the National Drug-Related Deaths Index
Drug-related deaths and deaths among drug users in Ireland 2011 figures from the National Drug-Related Deaths Index January 2014 Summary of 2011 results This update presents figures from the National Drug-Related
More informationApplications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.
Applications of High Resolution Mass Spectrometry in Forensic Toxicology Patrick Kyle, PhD pkyle@umc.edu Financial Disclosures Grant/Research Support: None Salary/Consultant Fees: None Board/Committee/Advisory
More informationWelcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017
Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug
More informationHow does polydrug use contribute to heroin overdose deaths? Risk to heroin users of concurrent use of pregabalin and gabapentin
How does polydrug use contribute to heroin overdose deaths? Risk to heroin users of concurrent use of pregabalin and gabapentin Graeme Henderson Suzanne Audrey Matt Hickman Abi Lyndon Rob Hill Claudia
More informationUrine Opioid Dependency Panel (UODP) 1
Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth,
More informationhypnotics and anxiolytics
hypnotics and anxiolytics Hypnotics and anxiolytics Most hypnotics and anxiolytics prescribed in Luxemburg are benzodiazepines and similar medications, such as Z-drugs (see table page 4). Legal status
More informationRisk and Benefit of the Concomitant Use of Benzodiazepines and Opiates
Risk and Benefit of the Concomitant Use of Benzodiazepines and Opiates Michael Angelini, M.A., BSPharm, Pharm.D., BCPP Associate Professor, MCPHS University Psychopharmacology Consultant UMass Medical
More informationNew Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) PDMP West Regional Meeting PMP Collaboration with the NM Department of Health April 26, 2018 New Mexico Board of Pharmacy Prescription
More informationUse and misuse of sedative drugs and related substances - Findings in the general population and in individuals with opioid dependence
Use and misuse of sedative drugs and related substances - Findings in the general population and in individuals with opioid dependence Abrahamsson, Tove 2016 Link to publication Citation for published
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK ccredited to Laboratory locations: Gavenny Court Brecon Road bergavenny Monmouthshire
More informationConversion of IV Midazolam. Unlike nearly all other benzodiazepine conversions, the conversion between intravenous midazolam and lorazepam has been
Conversion of IV Midazolam. Unlike nearly all other benzodiazepine conversions, the conversion between intravenous midazolam and lorazepam has been well studied in. Category: Main/ IV Manual and IV Compatibility
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
More informationPain Medication Management Program Monitors Patient Compliance
PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your
More informationDrug Related Deaths in Highland
Drug Related Deaths in Highland Carolyn Hunter-Rowe Research and Intelligence Specialist August 2017 Highland Alcohol and Drugs Partnership Larch House, Stoneyfield Business Park, Inverness, IV2 7PA Website:
More informationUrine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016
Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of
More informationWEDINOS Headlines 6,452. wedinos.org 5,806 BULLETIN. Samples. received. Samples. received. Samples. analysed. Samples. rejected
BULLETIN Issue 11 - Jan - Mar 2017 WEDINOS Quarterly Newsletter Collecting, Testing, Informing wedinos.org WEDINOS Headlines TOTAL number of samples received by WEDINOS October 2013 to March 2017 The WEDINOS
More informationOregon s PDMP: An epidemiological assist tool
Oregon s PDMP: An epidemiological assist tool Todd Beran Center for Prevention and Health Promotion Oregon Health Authority PDMP TTAC Webinar February 13, 2013 1 Acknowledgements Lisa Millet, MSH, Section
More informationNatural Deaths 61 Investigated/PND 14 Accidental Deaths 123 Suicides 37 Homicides 8 Stillborn 2 SUIDS 1 Cannot Be Determined 4 Pending 0
2016 Report for the Coroner's Office S. Timothy Warco Washington County, Pennsylvania Population Served, 2015 Estimate: 208,261 Area Served, Mi 2 861 Total cases reported to the Coroner's Office 2137 View
More informationEvaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.
Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure
More information4. Problem drug use Introduction
4. Problem drug use 4.1. Introduction Problem use: general context A set of studies and work has been conducted in recent years to establish a new estimate of the number of problematic drug users in France.
More informationDOF. Scheme Description. Drugs in Oral Fluid Scheme
DOF Drugs in Oral Fluid Scheme Scheme Description LGC Standards Proficiency Testing 1 Chamberhall Business Park Chamberhall Green Bury Lancashire BL9 0AP United Kingdom Telephone: +44 (0) 161 762 2500
More informationBEHAVIOURAL SCREENING OF DRUGS HYPNOTICS/SEDATIVES
BEHAVIOURAL SCREENING OF DRUGS I. PHARMACOLOGICAL PROPERTIES OF SOME CNS AFFECTIVE AGENTS HYPNOTICS/SEDATIVES The hypnotics and sedatives are one of the most widely prescribed classes of drugs on the market.
More informationDr. Smith. Roneet Lev, MD FACEP Chief, Emergency Department Scripps Mercy Hospital Chair, San Diego Prescription Drug Abuse Medical Task Force
Dr. Smith Roneet Lev, MD FACEP Chief, Emergency Department Scripps Mercy Hospital Chair, San Diego Prescription Drug Abuse Medical Task Force 1 1 How We Got Here 2 The Epidemic 3 4 San Diego Death Diaries
More informationDr Chris Ford Clinical Director IDHDP (International Doctors for Healthy Drug Policies) Thursday 16 th May 2013
Dr Chris Ford Clinical Director IDHDP (International Doctors for Healthy Drug Policies) Thursday 16 th May 2013 The Beginning Benzodiazepines always a problem Most loved Addiction 2004 Jaffe et al Not
More informationPrescription for Disaster: Impact of Drugs in our Society
Prescription for Disaster: Impact of Drugs in our Society What you can do about the epidemic of drug abuse in our communities 1 Florida Poison Information Center-Tampa 10/26/2012 Cynthia R. Lewis-Younger,
More informationMontgomery County Poisoning Death Review:
Wright State University CORE Scholar Unintentional Prescription Drug Poisoning Project Center for Interventions, Treatment and Addictions Research 5-6-214 Montgomery County Poisoning Death Review: 21-213
More informationwedinos.org WEDINOS Headlines 6,056 Synthetic Cannabinoid Receptor Agonists and the Law 5,058
BULLETIN Issue 10 - Oct - Dec 2016 WEDINOS Quarterly Newsletter Collecting, Testing, Informing wedinos.org WEDINOS Headlines TOTAL number of samples received by WEDINOS October 2013 to December 2016 The
More informationKøbenhavns Universitet
university of copenhagen Københavns Universitet Fatal poisoning among patients with drug addiction Simonsen, Kirsten Wiese; Christoffersen, Dorte J; Banner, Jytte; Linnet, Kristian; Andersen, Ljubica V
More informationTHE ROLE OF ALCOHOL, LICIT AND ILLICIT DRUGS IN TRAFFIC IN EASTERN EUROPE
THE ROLE OF ALCOHOL, LICIT AND ILLICIT DRUGS IN TRAFFIC IN EASTERN EUROPE T. Varga 1, M. Vali 2, R. Wachowiak 3, F. Longauer 4, M. Zorec-Karlovsek 5 1. Dept. of Forensic Medicine, University of Szeged,
More informationManaging drug misuse in pregnancy and beyond
Managing drug misuse in pregnancy and beyond Dr Emily Finch Clinical Director Addictions CAG, South London and Maudsley Foundation NHS Trust Rachel Evans, Adfam 1 / Aims of the session Update on management
More informationPain Medication Management Program Supports Patient Outcomes and Adherence
PeaceHealth Laboratories UPDATE 2015 Revised Edition Pain Medication Management Program Supports Patient Outcomes and Adherence BENEFITS Monitors analgesic medication adherence to ensure patient safety
More informationConflict of Interest Disclosure
Patient Rx Drug Misuse and Abuse: Compliance Toxicology Monitoring in Clinical Practice Toxicology Staff Andrea Terrell, Ph.D., DABCC Chief Scientific Officer George Behonick, Ph.D., DABFT, Manager, FBU
More informationFirst results collected by Argos, DCR in Strasbourg opened in november 2016
Photo Marine Saiah First results collected by Argos, DCR in Strasbourg opened in november 2016 Danièle BADER, Leader of Ithaque Association EMCDDA, DRID Meeting 18-20 september 2017 A crossborder experimentation
More informationA review of drug-related deaths in seven Northern European countries
A review of drug-related deaths in seven Northern European countries Tim Millar a & Andy McAuley b a) Division of Psychology & Mental Health, School of Health Sciences, The University of Manchester b)
More informationThe Drug Testing Process. Employer or Practice
Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine
More informationDAWN. In 2009, nearly 4.6 million emergency
Drug Abuse Warning Network The DAWN Report December 28, 2010 Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits In Brief In 2009, there were nearly
More informationIn 2009, nearly 4.6 million emergency
Drug Abuse Warning Network The DAWN Report December 28, 2010 Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits In Brief In 2009, there were nearly
More informationDesigner drugs and road safety in Japan
TECHNICAL CONSULTATION ON DRUG USE AND ROAD SAFETY WHO/HQ, GENEVA, SWITZERLAND, SALLE C 17 18 DECEMBER 2014 Designer drugs and road safety in Japan Kazuko Okamura National Research Institute of Police
More informationBree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT
Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup Opioid Prescribing Metrics - DRAFT Definitions: Days Supply: The total of all opioid prescriptions dispensed during the calendar quarter
More informationEvaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites
Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites Valérie Thibert 1, Norbert Dirsch 2, Johannes Engl 2, Martin Knirsch 2 1 Thermo Fisher Scientific,
More informationDriving and Pain. Guidance for Faculty of Pain Medicine Members
Driving and Pain Guidance for Faculty of Pain Medicine Members Introduction Road traffic accidents remain a significant public health problem in the UK. In 2016 there were over 180,000 casualties resulting
More informationData Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky
Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky Svetla Slavova, PhD Terry Bunn, PhD Bureau of Justice Assistance Research-Practitioner Partnership & Data-Driven Pilots
More informationEarlier arrests among apprehended drivers in Norway with heroin and ecstasy detection
Earlier arrests among apprehended drivers in Norway with heroin and ecstasy detection A. S. Christophersen¹, A. M. Hausken¹ and S. Skurtveit¹ ² ¹National Institute of Forensic Toxicology, P.O. Box 495
More informationLyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.
Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory Lyndsey.Knoy@wsp.wa.gov Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for
More informationEXPERT REPORT OF IN THE MATTER OF VS. INC., d/b/a IN THE DISTRICT COURT OF OKLAHOMA COUNTY STATE OF OKLAHOMA CASE NO. CONSULTOX, LIMITED
EXPERT REPORT OF RICHARD A. PARENT, PHD, DABT, FATS, RAC, ERT IN THE MATTER OF, AS SISTER, NEXT FRIEND AND SURVIVOR OF, DECEASED VS. INC., d/b/a IN THE DISTRICT COURT OF OKLAHOMA COUNTY STATE OF OKLAHOMA
More informationGreenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationOpioid Pain Contracts: A Resident Driven Quality Improvement Project
Opioid Pain Contracts: A Resident Driven Quality Improvement Project A Response to the Opioid Epidemic Dr. Phillip Knouse Dr. Victoria Montgomery Disclosure None Objectives Discuss the current Opioid Epidemic
More informationC E N T E R F O R C A R E I N N O V A T I O N S
C E N T E R F O R C A R E I N N O V A T I O N S B E N Z O D I A Z E P I N E S A N D B U P R E N O R P H I N E - S A F E T Y D R I V E N M E D I C A T I O N M A N A G E M E N T N O V E M B E R 1 6, 2 0
More informationDr Alistair Dunn. Lead Clinician Northland Health Community Mental Health & Addictions Northland DHB Whangarei
Dr Alistair Dunn Lead Clinician Northland Health Community Mental Health & Addictions Northland DHB Whangarei 8:30-9:25 WS #147: The Bottom Line; Tackling the Problem of Prescribed Drug Addiction 9:35-10:30
More informationSupplemental Digital Content
CNS Drugs The Relationship between Benzodiazepine Use and Traffic Accidents A Systematic Literature Review Beitske E. Smink, et al. Supplemental Digital Content This Supplemental Digital Content contains
More informationDr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.
David W. Oslin, MD University of Pennsylvania Philadelphia VAMC Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging. Dr. Oslin is a consultant to the Hazelden Betty
More informationMinneapolis/St. Paul, Minnesota Drug Abuse Trends: January 2014 Update
Minneapolis/St. Paul, Minnesota Drug Abuse Trends: January 2014 Update Carol Falkowski Drug Abuse Dialogues ABSTRACT Heroin and other opiate addiction continued to escalate in the Twin Cities in 2013.
More informationBenzodiazepines. CRIT program May Alex Walley, MD, MSc Assistant Professor of Medicine Boston University School of Medicine
Benzodiazepines CRIT program May 2010 Alex Walley, MD, MSc Assistant Professor of Medicine Boston University School of Medicine Medical Director, Opioid Treatment Program Boston Public Health Commission
More informationEpidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch
Epidemiology of non medical use of prescription drugs Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Monitoring of the drug use situation: Annual reports questionnaire
More informationMR04A3 An isoindoline derivative, New Sedative/Anesthetic Agent
MR04A3 An isoindoline derivative, ew Sedative/Anesthetic Agent ovember 2009 1 Introduction Sedatives are widely used in: Settings providing stressful and painful procedures Gastroenterology (colonoscopy
More informationINVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION
INVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION Jim GEROSTAMOULOS, Helen BATZIRIS, Olaf H. DRUMMER Victorian Institute of Forensic Medicine and Department of Forensic Medicine, Monash University, Southbank,
More information9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A
Prescription Drug Abuse Crises Outline 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A 1 1970s 1980s 2 The 1990s OXYCODONE Oxycodone/APAP OxyContin
More informationClose to Home A Recovery Brief WNC Recovery Recovery Ministries of the Episcopal Church
Close to Home A Recovery Brief WNC Recovery Recovery Ministries of the Episcopal Church Prayer for Victims of Addiction O blessed Lord, you ministered to all who came to you: Look with compassion upon
More informationDriving Under the Influence of Non-Alcohol Drugs An Update. Part II: Experimental Studies
Driving Under the Influence of Non-Alcohol Drugs An Update. Part II: Experimental Studies M. C. Strand*, H. Gjerde, J. Mørland Domain for Forensic Sciences Norwegian Institute of Public Health Oslo Norway
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationDAU. Scheme Description. Drugs of Abuse in Urine Proficiency Testing Scheme
DAU Drugs of Abuse in Urine Proficiency Testing Scheme Scheme Description LGC Standards Proficiency Testing 1 Chamberhall Business Park Chamberhall Green Bury Lancashire BL9 0AP United Kingdom Telephone:
More informationPhysician s Reference for Urine and Blood Drug Testing and Interpretation
Physician s Reference for Urine and Blood Drug Testing and Interpretation DETECTIMED PANEL Urine (test code 70195) Screen Confirmation Screen Confirmation Alcohol Ethanol Amphetamines Amphetamine Methamphetamine
More information